Company intelligence / Profile preview

Zuellig Group

Wan Chai, Hong Kong

Ownership: Private
Employees: ~12000
Development stage: Other

Overview

The Zuellig Group is a privately owned conglomerate founded in 1912 based in Hong Kong. It operates primarily as a healthcare and pharmaceutical distributor and solutions provider rather than as a biotech or drug development company. Its healthcare division, Zuellig Pharma, is Asia's leading integrated healthcare solutions company, operating across 13 markets in Asia-Pacific, serving over 200,000 medical facilities. The company offers comprehensive distribution solutions, cold chain logistics, clinical trial support, and regulatory affairs services.

Industry: Contract Research Organization

Partnerships

OrganonEli Lilly

Beyond the preview

Go deeper on Zuellig Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zuellig Group.

Explore the full profile